← All claims

Longevity & Aging · Metabolic & Cardiometabolic

testosterone therapy increases muscle mass and strength

In plain terms: Does testosterone therapy build muscle?

Strong support Longevity & Aging

Part of: 💊 Testosterone therapy (TRT)

RefutedContestedStrong support
consensus score 0.92

Yes — in men who genuinely have low testosterone, it reliably increases muscle mass and strength, and the effect is dose-dependent (one of TRT's most consistent benefits). Two caveats: injections work better than gels, and more muscle doesn't automatically mean better everyday physical function, especially in older men.

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

12 support 0 contradict 0 tested null 1 mixed · 13 sources, 11 independent groups

What the evidence shows

In men with low testosterone, testosterone therapy reliably **increases lean (fat-free) muscle mass and strength** — this is one of TRT's best-established effects. Multiple meta-analyses and classic dose-response trials show clear, dose-dependent gains (often 1.5-3 kg of lean mass, more at higher doses). The honest caveats: injectable testosterone works better than gels/patches, and gaining muscle

The evidence (13)

SourceGradeStanceQualityFinding
Krause Neto W et al.
2015 · Aging Male
meta-analysis supports moderate Meta 11 RCTs (men >60y): lean mass +3.59 kg pooled (high heterogeneity I2=98%).
Isidori AM et al.
2005 · Clin Endocrinol (Oxf)
meta-analysis supports high Meta 29 RCTs (n=1083): fat-free mass +1.6 kg (+2.7%); strength effect modest/heterogeneous.
Woodhouse LJ et al.
2003 · J Clin Endocrinol Metab
RCT supports moderate Dose-response RCT: T dose predicted FFM gain; muscle volume rose dose-dependently.
Snyder PJ et al.
2016 · N Engl J Med
RCT mixed high Testosterone Trials (n=790): increased walking distance in pooled analysis but no clear physical-function benefit; strength not a primary outcome.
Bhasin S et al.
2001 · Am J Physiol Endocrinol Metab
RCT supports high Dose-response RCT: fat-free mass increased dose-dependently up to +7.9 kg at highest dose; strength tracked dose.
Traish AM
2016 · Curr Opin Endocrinol Diabetes Obes
mechanism supports low Review: T therapy consistently increases lean body mass and reduces fat mass across trials.
Parahiba SM et al.
2020 · Exp Gerontol
meta-analysis supports moderate Meta 11 RCTs: lean body mass +2.54 kg; handgrip +1.58 kgf; leg strength increased.
Srinivas-Shankar U et al.
2010 · J Clin Endocrinol Metab
RCT supports moderate RCT (frail elderly, n=274): lean mass up, knee-extension strength up vs placebo at 6 months.
Guo C et al.
2016 · Andrologia
meta-analysis supports moderate Meta 16 RCTs: lean body mass +1.22 kg (95% CI 0.33-2.11).
Zhang J et al.
2019 · Aging Male
meta-analysis supports low Meta 7 RCTs: increased lean mass and sex hormones; overall clinical benefit called limited.
Skinner JW et al.
2018 · J Cachexia Sarcopenia Muscle
meta-analysis supports high Meta 31 RCTs: TRT increased fat-free mass (ES 1.20) and total-body strength (ES 0.90); IM route 3-5x more effective than transdermal.
Storer TW et al.
2008 · J Clin Endocrinol Metab
RCT supports moderate Dose-response RCT (60-75y): dose-dependent gains in muscle mass and max leg-press strength; no change in physical function.
Mangolim AS et al.
2022 · Andrology
meta-analysis supports moderate Meta 16 RCTs (obese men): ~2 kg lean body mass gain (moderate-certainty).

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.